Trial intelligence / Profile preview

Linaclotide for functional constipation in children

IRCT20220409054467N6Phase 3Recruiting

Sponsor
Tehran University of Medical Sciences
Start
Jun 2026
Modality
Peptides
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in functional constipation (FC) comparing Linaclotide + polyethylene glycol with Placebo + polyethylene glycol (2 arms). Primary endpoints: Number of bowel movements and Stool type according to Bristol Stool Form Scale. Started Jun 2026; status: recruiting.

02

Drugs

linaclotide
03

Conditions

functional constipation (FC)

Beyond the preview

Go deeper on IRCT20220409054467N6.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20220409054467N6.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call